[Summary] Biopharmaceutical R&D company
Dizal Pharmaceutical (Stock Code: 688192) is an innovative biopharmaceutical company focused on the research, development, and commercialization of innovative therapies for malignant tumors and immune diseases. The company adheres to the R&D concept of source innovation, aiming to launch first-in-class drugs and breakthrough-potential treatments to fill unmet clinical needs globally. Based on advanced translational science and new drug molecular design and screening technology platforms, the company has established a product pipeline of five assets with global competitiveness, with two leading products in global pivotal clinical trials, one of which has been approved for marketing.
Dizal Pharmaceutical Co., Ltd (Ticker: 688192) is a commercial stage biopharmaceutical company. At Dizal we aspire to discover and develop differentiated therapeutics for the treatment of cancer and immunological diseases. Building on our extensive expertise in translational science and molecular design, we have established an internationally competitive portfolio of five clinical-stage assets with two leading assets in global pivotal studies and one already approved.
What does Dizal (Jiangsu) Pharmaceutical Joint-stock Co., Ltd. require? Who is Dizal Pharmaceutical hiring? Dizal Pharmaceutical recruitment: 销售类占比最多占62%,其次是医疗卫生/美容保健类占29.8%. What education can get in at Dizal Pharmaceutical? 本科占比最多占60.8%,其次是大专占29%. High education required at Dizal Pharmaceutical? 硕士占3.3%. Work experience required at Dizal Pharmaceutical? 不限占比最多占39.6%,其次是1-3年占32.2%. Where are the job locations at Dizal Pharmaceutical? 上海占比最多占24.1%,其次是无锡占11%. Based on job postings from the past year, for reference only.
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows